ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Interfant-06: International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic or Biphenotypic Leukemia
Protocol ID
Interfant-06
Condition/s
Leukaemia
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Dutch Childhood Oncology Group
Collaborators
BFM Germany
CORS Monza Italy
Associazione Italiana Ematologia Oncologia Pediatrica
BFM Austria
CLCG France Belgium Portugal
COALL Germany
CPH, Czech republic
DFCI consortium USA
FRALLE France
Hong Kong
MD Anderson USA
NOPHO Scandinavian countries
PINDA, Chile
PPLLSG Poland
Seattle USA
SJCRH USA
UKCCSG United Kingdom
Trial Status
Closed to Recruitment
Study Type
Registry
Phase
Phase 3
Age Eligibility
up to 1 year
International registry ID's
NCT00550992
Back to Registry
Study Title Interfant-06: International Collaborative Treatment Protocol for Infants Under One Year With Acute Lymphoblastic or Biphenotypic Leukemia
Protocol ID Interfant-06
Disease (Sub Disease) Leukaemia
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ Dutch Childhood Oncology Group
Collaborators BFM Germany/ CORS Monza Italy/ Associazione Italiana Ematologia Oncologia Pediatrica/ BFM Austria/ CLCG France Belgium Portugal/ COALL Germany/ CPH, Czech republic/ DFCI consortium USA/ FRALLE France/ Hong Kong/ MD Anderson USA/ NOPHO Scandinavian countries/ PINDA, Chile/ PPLLSG Poland/ Seattle USA/ SJCRH USA/ UKCCSG United Kingdom
Trial Status Closed to Recruitment
Trial Open Date 15/01/2006
Study Type Registry
Phase Phase 3
Age Eligibility up to 1 year
International registry ID's NCT00550992

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168